BVS vs L · rev $573.3M vs P/E 14, rev $18.45B
Bioventus Inc (BVS) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
BVS currently screens at market cap $495.1M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the BVS and L stock pages for the full models.
Not investment advice.